NRIX
Nurix Therapeutics Inc
23.00$
-1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.9% | +9.4% | -27.1% | +4.1% | +5.5% | +38.9% | +138.7% | -82.1% | +72.0% | -54.0% | +44.6% | – | |
| – | +3.9% | +0.6% | -2.2% | +13.4% | +21.2% | +3.6% | +12.1% | -93.6% | -7.4% | +1,716.8% | -95.4% | – | |
| – | – | – | – | – | – | – | – | – | +209.1% | -970.6% | – | – | |
| – | +3.9% | +0.6% | -2.2% | +13.4% | +21.2% | +3.6% | +12.1% | +10.3% | -6.1% | +4.0% | +4.2% | – | |
| – | +1.5% | +9.5% | -0.8% | +0.1% | -8.5% | +8.7% | +22.6% | -7.9% | +3.7% | +7.0% | +6.7% | – | |
| – | +1.5% | +9.5% | -0.8% | +0.1% | -8.5% | +8.7% | +22.6% | +560.1% | -2.4% | -84.1% | +580.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +130.4% | -98.9% | +0.0% | -8.9% | -90.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.